Arkolith/Insider Trading/UTHR/Form 4

Rothblatt Martine A

Chairperson & CEO, DirectorUNITED THERAPEUTICS Corp (UTHR) · full profile →Form 4 · filed Jul 14, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$5.1M
Net Open-Market Flow
-$5.1M
Transactions
11
10 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 13, 2026Option exercise(M)10K$135.42$1.3M50K
Jul 13, 2026Sell(S)1K$533.70$544K49K
Jul 13, 2026Sell(S)2K$534.63$1.2M47K
Jul 13, 2026Sell(S)2K$535.47$1.2M45K
Jul 13, 2026Sell(S)2K$536.52$1.2M42K
Jul 13, 2026Sell(S)665$537.66$358K42K
Jul 13, 2026Sell(S)409$538.60$220K41K
Jul 13, 2026Sell(S)320$539.60$173K41K
Jul 13, 2026Sell(S)360$541.10$195K41K
Jul 13, 2026Sell(S)40$542.80$22K41K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 13, 2026Option exercise(M)10K—$011K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001106578-26-000097) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML